alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit
31.2




CERTIFICATION
OF PRINCIPAL FINANCIAL OFFICER


Rule
13a–14(a)/15d–14(a) Certification




I,
Clifford L. Flowers, Chief Financial Officer of the registrant, certify
that:





1.           I
have reviewed this quarterly report on Form 10-Q for the quarterly period ended
November 30, 2008 of Patriot Scientific Corporation;





2.           Based
on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;





3.           Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;





4.           The
registrant's other certifying officer(s) and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the registrant and have:





(a)           Designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this report is being prepared;





(b)           Evaluated
the effectiveness of the registrant's disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and





(c)           Disclosed
in this report any change in the registrant's internal control over financial
reporting that occurred during the registrant's most recent fiscal quarter (the
registrant's fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and





5.           The
registrant's other certifying officer(s) and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):





(a)           All
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the registrant's ability to record, process, summarize and
report financial information; and





(b)           Any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal control over financial
reporting.





Date:
January 9, 2009


/s/
      Clifford L. FlowersClifford
      L. Flowers
              Chief Financial
      Officer
Exhibit 32.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350 In connection with the accompanying Quarterly Report On Form 10-Q of Laxai Pharma, Ltd. (the "Company") for the quarter ending March 31, 2010, I, J. Ram Ajjarapu, Chief Executive Officer of the Company hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:  1. Such Quarterly Report on Form 10-Q for the quarter ending March 31, 2010, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  2. The information contained in such Quarterly Report on Form 10-Q for the quarter ending March 31, 2010, fairly presents, in all material respects, the financial condition and results of operations of the Company.  Dated:  May 20, 2010 LAXAI PHARMA, LTD. By:  /s/ J. Ram Ajjarapu J. Ram Ajjarapu  Exhibit 32.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350 In connection with the accompanying Quarterly Report On Form 10-Q of Laxai Pharma, Ltd. (the "Company") for the quarter ending March 31, 2010, I, J. Ram Ajjarapu, Chief Financial Officer of the Company hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:  1. Such Quarterly Report on Form 10-Q for the quarter ending March 31, 2010, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  2. The information contained in such Quarterly Report on Form 10-Q for the quarter ending March 31, 2010, fairly presents, in all material respects, the financial condition and results of operations of the Company.  Dated:  May 20, 2010 LAXAI PHARMA, LTD. By:  /s/ J. Ram Ajjarapu J. Ram Ajjarapu
#### Silvia G. SINGLETON, Plaintiff-Appellant, v. SOCIAL SECURITY ADMINISTRATION, Defendant-Appellee.

No. 04-1510.

United States Court of Appeals, Fourth Circuit.

Submitted Dec. 16, 2004.

Decided Dec. 20, 2004.

*259Silvia G. Singleton, Appellant pro se.

Before MICHAEL, KING, and SHEDD, Circuit Judges.

Affirmed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).

PER CURIAM.

Silvia G. Singleton appeals from the district court’s order dismissing her civil action against the Social Security Administration. Our review of the record and the district court’s opinion adopting the magistrate judge’s recommendation discloses no reversible error. Accordingly, we affirm for the reasons stated by the district court. *See Singleton v. Social Security Admin.,*No. CA-03-3242-3 (D.S.C. Mar. 24, 2004). We deny Singleton’s motion for preparation of a transcript at government expense and dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED*
Exhibit 31

CERTIFICATION


I, JOHN P. GRAZER, certify that:

1. I have reviewed this annual report on Form 10-K, and all reports on
Form 8-K containing distribution or servicing reports filed in respect of
 periods included in the year covered by this annual report, of Ameriquest
 Mortgage Securities, Inc. 2004-R4:

2. Based on my knowledge, the information in these reports, taken as a
whole, does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading as of the
last day of the period covered by this annual report;

3. Based on my knowledge, the distribution or servicing information
required to be provided to the trustee by the servicer under the pooling
and servicing, or similar, agreement, for inclusion is included in these
reports;

4. I am responsible for reviewing the activities performed by the servicer
under the pooling and servicing, or similar agreement and based upon my
knowledge and the annual compliance required under that agreement, and except
as disclosed in the reports, the servicer has fulfilled its obligations under
that agreement; and

5. The reports disclose all significant deficiencies relating to the
servicer's compliance with the minimum servicing standards based upon the
report provided by and independent public account, after conducting a review
in compliance with the Uniform Single Attestation Program for Mortgage
Bankers or similar procedure, as set forth in the pooling and servicing, or
similar, agreement, that is included in these reports.


In giving the certifications above, I have reasonably relied on information
provided to me by the following unaffiliated parties: Deutsche Bank National
Trust Company.

<page>



Date: March 1, 2005

AMERIQUEST MORTGAGE SECURITIES INC.


/s/: John P Grazer
John P Grazer
CFO
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JAN-30-1999
<PERIOD-START>                             FEB-01-1998
<PERIOD-END>                               MAY-02-1998
<CASH>                                           2,817
<SECURITIES>                                     8,122
<RECEIVABLES>                                    3,523
<ALLOWANCES>                                         0
<INVENTORY>                                     39,357
<CURRENT-ASSETS>                                55,233
<PP&E>                                          36,794
<DEPRECIATION>                                  10,338
<TOTAL-ASSETS>                                  81,689
<CURRENT-LIABILITIES>                           19,653
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            88
<OTHER-SE>                                      60,067
<TOTAL-LIABILITY-AND-EQUITY>                    81,689
<SALES>                                         45,026
<TOTAL-REVENUES>                                45,026
<CGS>                                           32,324
<TOTAL-COSTS>                                   32,324
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  2,267
<INCOME-TAX>                                       850
<INCOME-CONTINUING>                              1,417
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,417
<EPS-PRIMARY>                                      .16
<EPS-DILUTED>                                      .16
        

</TABLE>
#### Jos. Chandet *v.*James Q. Gordon and Wife.

Descent and Distribution — Timber.

The timber on land -which passes to the wife on the death of the husband belongs to the wife.

New Trial — By Court of Appeals — Former Verdicts.

Where other trials of the same case have resulted in a judgment against appellant, the Court of Appeals will be reluctant to' award a new trial under such circumstances.

appeal, prom McCracken circuit ¡court.

February 13, 1873.

Opinion by

Judge Petees :

The title to the land from which the timber was cut on the death of Mr. Winters passed to appellee, Catherine; a portion of it was cut and removed after the death of the father, and to that which was not severed from; the land in his lifetime, she was unquestionably entitled. There is some conflict in the evidence as to the quantity severed after the death of Mr. Winters. But there have been three trials of the case in the court below, all of which resulted disastrously to appellant, and this court would very reluctantly interpose to award a new trial under such circumstances. The law and facts on the last trial were submitted to the court, and unless *452the judgment was palpably against the evidence we would not be authorized to interfere, which is not the case, wherefore the judgment is *affirmed.*

*P. D. Yeiser, for appellant.*

-, *for appellee.*
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan

September 10, 2007 Clifford W. Taylor,
Chief Justice

Michael F. Cavanagh
Elizabeth A. Weaver 133765 Marilyn Kelly Maura D. Corrigan Robert P. Young, Jr. Stephen J. Markman, PEOPLE OF THE CI TY OF DEARBORN, Justices Plaintiff-Appellee,

v SC: 133765 COA: 272342 Wayne CC: 06-100001-01 BOGDAN F. MUZYK, 19 th DC: 04 C247391 Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application for leave to appeal the March 1, 2007 order of the Court of Appeals is considered, and it is DENIED, because we are not persuaded that the questions presented should be reviewed by this Court.

d0830 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

September 10, 2007

Clerk
POWER OF ATTORNEY AND SIGNATURES

We, the undersigned officers and directors of Mediscience Technology Corp.
hereby severally constitute and appoint Peter Katevatis, our true and lawful
attorney, with full power to sign for us and in our names in the capacities
indicated below, any amendments to this report on form 10-KSB, and generally to
do all things in our names and on our behalf in such capacities to enable
Mediscience Technology Corp. to comply with the provisions of the Securities
Exchange Act of 1934, as amended, and all the requirements of the Securities and
Exchange Commission.

Pursuant to the requirements of section 13 or 15(d) of the Securities and
Exchange Act of 1934, this report has been signed below by the following persons
on behalf of the Registrant and in the capacities and on the date indicated.

Signature                                            Title
Date
-----------------------

/s/ Peter Katevatis                  Chairman of the Board, Principle Officer
-----------------------                  and Financial Officer
Peter Katevatis, Esq.
June 19, 2000


/s/ William Armstrong
-----------------------
William Armstrong                                  Director
June 19, 2000


/s/ Mathew J. Culligan
-----------------------
Mathew J. Culligan                                 Director
June 19, 2000


/s/ John M. Kennedy
-----------------------
John M. Kennedy                                    Director
June 19, 2000


/s/ Michael N. Kouvatas
-----------------------
Michael N. Kouvatas, Esq.                          Director
June 19, 2000


/s/ John P, Matheu
-----------------------
John P.Matheu                                      Director
June 19, 2000
I 

108TH CONGRESS 

2D SESSION H. R. 4127 

To amend the Public Health Service Act to authorize grants to hospitals 

for measurement-based strategies to improve the quality and efficiency 

of health care. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 2, 2004 

Mr. KIND (for himself and Mr. UPTON) introduced the following bill; which 

was referred to the Committee on Energy and Commerce 

A BILL 

To amend the Public Health Service Act to authorize grants 

to hospitals for measurement-based strategies to improve 

the quality and efficiency of health care. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Improving Efficiency 

5 and Quality in Hospitals Act of 2004’’. 

6 SEC. 2. FINDINGS. 

7 The Congress finds as follows: 

8 (1) The goals of the Institute of Medicine, as 

9 expressed in its report entitled ‘‘Crossing the Quality 
2 

•HR 4127 IH 

1 Chasm: A New Health System for the 21st Cen2 tury’’, are to increase quality and efficiency in hos3 pitals and health care systems. 

4 (2) Approaches such as Six Sigma, Root Cause 

5 Analysis, and Failure Mode and Effect Analysis 

6 have succeeded in reducing errors, cutting costs, and 

7 improving services. 

8 SEC. 3. DEMONSTRATION PROJECT FOR IMPROVING QUAL9 ITY AND EFFICIENCY AT HOSPITALS. 

10 Part A of title IX of the Public Health Service Act 

11 (42 U.S.C. 299 et seq.) is amended by adding at the end 

12 the following: 

13 ‘‘SEC. 904. DEMONSTRATION PROJECT FOR IMPROVING 

14 QUALITY AND EFFICIENCY AT HOSPITALS. 

15 ‘‘(a) GRANTS.—The Secretary, acting through the 

16 Director, may make grants to hospitals for developing and 

17 implementing measurement-based strategies to improve 

18 the quality and efficiency of health care. 

19 ‘‘(b) USE OF FUNDS.—The Secretary may not make 

20 a grant to a hospital under this section unless the hospital 

21 agrees to use the grant, with respect to health care at the 

22 hospital, to improve the following: 

23 ‘‘(1) Safety. 

24 ‘‘(2) Injury avoidance. 
3 

•HR 4127 IH 

1 ‘‘(3) Effectiveness of services, based on sci2 entific knowledge and focusing on patients. 

3 ‘‘(4) Timeliness. 

4 ‘‘(5) Efficiency. 

5 ‘‘(6) Equitable distribution of services. 

6 ‘‘(c) DISTRIBUTION.—The Secretary shall make 

7 grants under this section to urban hospitals, non-urban 

8 hospitals, teaching hospitals, and hospitals with fewer 

9 than 50 acute care beds. 

10 ‘‘(d) REPORT.—Not later than 3 years after the date 

11 of the enactment of this section, the Secretary shall con12 duct an assessment of the results of grants under this sec13 tion and submit to the Congress a report on the findings 

14 and conclusions of the assessment. 

15 ‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 

16 are authorized to be appropriated to carry out this section 

17 such sums as may be necessary for the period of fiscal 

18 years 2005 through 2007.’’. 

Æ
EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of American Patriot Financial Group, Inc. (the "Registrant") on Form 10-K for the period ending
December 31, 2008, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, T. Don Waddell, Chief Financial Officer of the Registrant, certify, pursuant to 18
U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)   The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)   The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

/s/ T. DON WADDELL T. Don Waddell Chief Financial OfficerAmerican Patriot Financial Group, Inc.
April 15, 2009


---



QuickLinks
IN THE SUPREME COURT OF PENNSYLVANIA

WESTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

JEFFREY ALAN OLSON,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 111 WAL 2018

Petition for Allowance of Appeal from 

the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 7th day of August, 2018, the Petition for Allowance of Appeal is 

GRANTED. The issues, rephrased for clarity, are:

a. Does Birchfield v. North Dakota, ––– U.S. ––––, 136 S.Ct. 2160, 195 

L.Ed.2d 560 (2016), apply retroactively where the petitioner challenges the 

legality of his sentence through a timely petition for post-conviction relief?

b. Does Birchfield v. North Dakota, ––– U.S. ––––, 136 S.Ct. 2160, 195 

L.Ed.2d 560 (2016), render enhanced criminal penalties for blood test 

refusal under 75 Pa.C.S. §§ 3803–3804 illegal?
Hardware 

Heterogeneity at NIST

DEREK JUBA

2023-12-07
NIST Clusters

Raritan

◦ ~1000 heterogenous nodes, mostly Intel CPU, mostly no GPU

Enki

◦ 13 nodes, IBM Power9 CPU, Nvidia V100 GPU

Nisaba

◦ 4 nodes (Nvidia DGX), Intel Xeon CPU, Nvidia V100 GPU

Many others...

2
Information Systems Group Cluster

Nodes

◦ 21 Heterogeneous

CPUs

◦ Intel Xeon, AMD Ryzen, AMD EPYC

GPUs

◦ None, TITAN RTX, GeForce 3090, V100, P100, A10, A100 (PCIE-40GB, PCIE-80GB, SXM4-80GB), H100

RAM

◦ 128 GiB to 2 TiB

3
Points of Heterogeneity

CPU Architecture: x86, Power ISA

◦ Extensions: FMA, SSE, AVX, etc.

GPU "Architecture": Nvidia, AMD, Intel

◦ Compute Capability

RAM Size

Exotic Hardware

◦ Tensor Processing Units, Quantum Processing Units, FPGAs, Xeon Phi, etc.

4
CUDA Backward and Forward 

Compatibility

CUDA SDK

version(s) Tesla Fermi Kepler(early)

Kepler

(late) Maxwell Pascal Volta Turing Ampere AdaLovelace Hopper

1.0 1.0 – 1.1

1.1 1.0 – 1.1+x

2.0 1.0 – 1.1+x

2.1 - 2.3.1 1.0 – 1.3

3.0 - 3.1 1.0 2.0

3.2 1.0 2.1

4.0 - 4.2 1.0 2.1

5.0 - 5.5 1.0 3.5

6.0 1.0 3.5

6.5 1.1 5.x

7.0 - 7.5 2.0 5.x

8.0 2.0 6.x

9.0 - 9.2 3.0 7.0

10.0 - 10.2 3.0 7.5

11.0 3.5 8.0

11.1 - 11.4 3.5 8.6

11.5 - 11.7.1 3.5 8.7

11.8 3.5 9.0

12.0 - 12.3 5.0 9.0

Source: Wikipedia 5
NIST Issues with CUDA Forward 

Compatibility

Received container which included pytorch

◦ Initially ran on V100 GPU

◦ Later, could not run on A100 GPU

Why?

6
NIST Issues with CUDA Forward 

Compatibility

CUDA Compilation

◦ NVCC compiler translates CUDA to PTX

◦ CUDA driver translates PTX to executable binary

CUDA applications are meant to ship with PTX

◦ CUDA driver compiles PTX for user's hardware at runtime

Pytorch shipped with only executable binaries...

◦ Just update Pytorch!

◦ Not in a container...

7
Thank You

A N Y M E N T I O N O F C O M M E R C I A L P R O D U C T S I S F O R I N F O R M A T I O N O N L Y ; I T D O E S N O T I M P L Y R E C O M M E N D AT I O N O R 

E N D O R S E M E N T B Y N I S T.

8
How to Obtain Support

for the NIST‐Guest Network

Where can I get help?   

The NIST Information Technology Assistance Center (iTAC) is available for limited support Monday

through Friday, 7:30am‐7:00pm, Eastern UTC‐5. Users seeking connectivity assistance may contact iTAC

in Gaithersburg, Maryland at 301‐975‐5375 or Boulder, Colorado, at 303‐497‐5375.

What support can I get?

1. Support is limited to devices used in support of the NIST mission.

2. Support is limited to the following actions:

a. Step through connection instructions; or

b. Verify if the device has been blocked due to a security incident (e.g., malware or misuse).

3. Prior to requesting support of a non‐NIST device the owner must demonstrate:

a. all outstanding operating system critical/high‐level patches have been successfully installed;

b. anti‐virus software is installed, active (i.e., no expired trial versions) and has up‐to‐date

definitions; AND

c. any virus incidents reported by anti‐virus software have been quarantined or removed.

4. Support will not be provided until all the items defined in #3 are in place.

5. Device owners are advised to:

a. Implement instructions provided by iTAC;

b. Bring associated plugs or cords; and

c. Operate the device controls (keyboard, mouse, screen, etc.).
1 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF ILLINOIS 

 EASTERN DIVISION 

ASIF J. POONJA, individually and on behalf 

of similarly situated individuals, 

Plaintiff, 

v. 

KELLY SERVICES, INC., a Delaware 

corporation, 

Defendant. 

Case No. 20-CV-04388 

Hon. Robert M. Dow, Jr. 

Hon. Magistrate Mara Valdez 

JOINT STIPULATION OF DISMISSAL WITH PREJUDICE 

Plaintiff Asif J. Poonja and Defendant Kelly Services, Inc., by and through their counsel, 

hereby request that the Court dismiss this action in its entirety with prejudice pursuant to Fed. R. 

Civ. P. 41(a)(1)(A), with each party to bear its own attorneys’ fees, expenses, and costs in 

connection with this action. 

Dated: December 21, 2021 Respectfully submitted, 

/s/ Eugene Y. Turin (with permission) 

Eugene Y. Turin 

(eturin@mcgpc.com)) 

MCGUIRE LAW, P.C. 

55 W. Wacker Dr., 9th Floor 

Chicago, IL 60601 

Attorney for Plaintiff 

/s/ Gerald L. Maatman, Jr. 

Gerald L. Maatman, Jr. 

(gmaatman@seyfarth.com) 

Jennifer A. Riley 

(jriley@seyfarth.com) 

Kristine R. Argentine 

(kargentine@seyfarth.com) 

SEYFARTH SHAW LLP 

233 South Wacker Drive 

Suite 8000 

Chicago, Illinois 60606 

Telephone: (312) 460-5000 

Attorneys for Defendant 

Case: 1:20-cv-04388 Document #: 54 Filed: 12/21/21 Page 1 of 2 PageID #:308
2 

CERTIFICATE OF SERVICE 

The undersigned, an attorney, certifies that on December 21, 2021, he caused a true and 

correct copy of the foregoing to be served via the Court’s ECF/electronic mailing system upon 

all parties of record. 

s/ Gerald L. Maatman, Jr. 

Case: 1:20-cv-04388 Document #: 54 Filed: 12/21/21 Page 2 of 2 PageID #:309